The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study

© 2018 Wiley Periodicals, Inc. Background: Epidermal growth factor (EGF) is one of the important peptides in wound healing process. The effects of EGF have been increasingly studied in various types of ulcers. However, data on postablative laser resurfacing wound is still limited. Objectives: To eva...

Full description

Saved in:
Bibliographic Details
Main Authors: Thanya Techapichetvanich, Rungsima Wanitphakdeedecha, Thanawan Iamphonrat, Weeranut Phothong, Sasima Eimpunth, Inneke Jane Hidajat, Woraphong Manuskiatti
Other Authors: Universitas Katolik Indonesia Atma Jaya
Format: Article
Published: 2019
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/46285
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.46285
record_format dspace
spelling th-mahidol.462852019-08-23T18:41:31Z The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study Thanya Techapichetvanich Rungsima Wanitphakdeedecha Thanawan Iamphonrat Weeranut Phothong Sasima Eimpunth Inneke Jane Hidajat Woraphong Manuskiatti Universitas Katolik Indonesia Atma Jaya Faculty of Medicine, Siriraj Hospital, Mahidol University Medicine © 2018 Wiley Periodicals, Inc. Background: Epidermal growth factor (EGF) is one of the important peptides in wound healing process. The effects of EGF have been increasingly studied in various types of ulcers. However, data on postablative laser resurfacing wound is still limited. Objectives: To evaluate the effects of the topical EGF ointment on wound healing process and postinflammatory hyperpigmentation (PIH) prevention after fractional ablative laser resurfacing. Materials and methods: This is a randomized split-face study. Nineteen healthy subjects were enrolled and completed follow up protocol. Patients received single treatment of fractional carbon dioxide laser on both cheeks. After randomization, each patient was assigned to apply one side of the face with topical EGF ointment and another side with petrolatum. Wound healing was evaluated by duration of scab shedding, duration of postlaser erythema, erythema index, and transepidermal water loss on the daily follow up period of seven days after treatment. PIH was evaluated at 2, 3 weeks and 1, 2 months follow up by photographs and melanin index. Results: Most of patients were female with Fitzpatrick skin phototype III to V. Comparing with control (petrolatum), EGF treated side showed no significant difference in duration of scab shedding, duration of postlaser erythema, erythema index, and transepidermal water loss (P-value =.58,.22,.78, and.51, respectively). Incidence of PIH was 52.6% on EGF side and 57.9% on petrolatum side, however, it was not statistically different (P =.56). The melanin index was also not different as well (P =.96). Conclusion: Topical EGF might provide significant wound healing stimulation for chronic wound more than acute wound. Further studies, especially in post laser wound or other cosmetic purposes are needed. 2019-08-23T11:41:31Z 2019-08-23T11:41:31Z 2018-10-01 Article Journal of Cosmetic Dermatology. Vol.17, No.5 (2018), 756-761 10.1111/jocd.12691 14732165 14732130 2-s2.0-85054704997 https://repository.li.mahidol.ac.th/handle/123456789/46285 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85054704997&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Medicine
spellingShingle Medicine
Thanya Techapichetvanich
Rungsima Wanitphakdeedecha
Thanawan Iamphonrat
Weeranut Phothong
Sasima Eimpunth
Inneke Jane Hidajat
Woraphong Manuskiatti
The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study
description © 2018 Wiley Periodicals, Inc. Background: Epidermal growth factor (EGF) is one of the important peptides in wound healing process. The effects of EGF have been increasingly studied in various types of ulcers. However, data on postablative laser resurfacing wound is still limited. Objectives: To evaluate the effects of the topical EGF ointment on wound healing process and postinflammatory hyperpigmentation (PIH) prevention after fractional ablative laser resurfacing. Materials and methods: This is a randomized split-face study. Nineteen healthy subjects were enrolled and completed follow up protocol. Patients received single treatment of fractional carbon dioxide laser on both cheeks. After randomization, each patient was assigned to apply one side of the face with topical EGF ointment and another side with petrolatum. Wound healing was evaluated by duration of scab shedding, duration of postlaser erythema, erythema index, and transepidermal water loss on the daily follow up period of seven days after treatment. PIH was evaluated at 2, 3 weeks and 1, 2 months follow up by photographs and melanin index. Results: Most of patients were female with Fitzpatrick skin phototype III to V. Comparing with control (petrolatum), EGF treated side showed no significant difference in duration of scab shedding, duration of postlaser erythema, erythema index, and transepidermal water loss (P-value =.58,.22,.78, and.51, respectively). Incidence of PIH was 52.6% on EGF side and 57.9% on petrolatum side, however, it was not statistically different (P =.56). The melanin index was also not different as well (P =.96). Conclusion: Topical EGF might provide significant wound healing stimulation for chronic wound more than acute wound. Further studies, especially in post laser wound or other cosmetic purposes are needed.
author2 Universitas Katolik Indonesia Atma Jaya
author_facet Universitas Katolik Indonesia Atma Jaya
Thanya Techapichetvanich
Rungsima Wanitphakdeedecha
Thanawan Iamphonrat
Weeranut Phothong
Sasima Eimpunth
Inneke Jane Hidajat
Woraphong Manuskiatti
format Article
author Thanya Techapichetvanich
Rungsima Wanitphakdeedecha
Thanawan Iamphonrat
Weeranut Phothong
Sasima Eimpunth
Inneke Jane Hidajat
Woraphong Manuskiatti
author_sort Thanya Techapichetvanich
title The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study
title_short The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study
title_full The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study
title_fullStr The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study
title_full_unstemmed The effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: A split-face randomized controlled study
title_sort effects of recombinant human epidermal growth factor containing ointment on wound healing and post inflammatory hyperpigmentation prevention after fractional ablative skin resurfacing: a split-face randomized controlled study
publishDate 2019
url https://repository.li.mahidol.ac.th/handle/123456789/46285
_version_ 1763492070212763648